2 completed, 1 not yet recruiting. 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Cilostazol 100 mg Tablets: new trials by email Literature Review of Cilostazol 100 mg Tablets trials Research Report on Cilostazol 100 mg Tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cilostazol for Prevention of Recurrent Stroke Trial Cilostazol 100 mg Tablets, Placebo - Stroke Recurrence, Myocardial Infarction | Phase 3 | Not yet recruiting | Stanford University | 2000 | 2026-10-01 | 2026-10-26 |
| Fasted Bioavailability Study of Cilostazol Tablets, 100 mg Cilostazol 100 mg Tablets, Cilostazol (Pletal®) 100 mg Tablets - Therapeutic Equivalency | Phase 1 | Completed | Mutual Pharmaceutical Company, Inc. | 32 | 2004-03-01 | 2009-12-22 |
| Cilostazol 100 mg Tablet Formulations Under Fasting Conditions Cilostazol 100 mg tablets, Pletal® 100 mg tablets - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 36 | 2003-11-01 | 2024-08-19 |
Ischemic Attack, Transient (1) · Ischemic Stroke (1) · Myocardial Infarction (1) · Stroke (1)
Mutual Pharmaceutical Company, Inc. (1) · Stanford University (1) · Teva Pharmaceuticals USA (1)
United States (2)
Dilip K Guha-Ray, M.D. (1) · Maarten Lansberg, MD, PhD (1) · Steven Herrmann, M.D., Ph. D. (1)
1UG3NS133209-01A1 (1)